Humana (HUM) EV to EBITDA (2009 - 2026)

Humana (HUM) has reported EV to EBITDA for 18 consecutive years, with 15.51 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 158.8% year-over-year to 15.51 in Q2 2026; TTM through Jun 2026 was 6.93, a 270.65% increase from a year earlier, with the FY2025 full-year figure at 3.18, up 7.8% from the prior year.
• EV to EBITDA was 15.51 for Q2 2026 at Humana, up from 0.56 in the prior quarter.
• Over five years, EV to EBITDA peaked at 141.91 in Q4 2022 and troughed at 269.62 in Q4 2023.
• A 5-year average of 2.19 and a median of 15.1 in 2024 frame the typical range for EV to EBITDA.
• Across the five-year window, EV to EBITDA plunged 289.99% in 2023 and soared 158.8% in 2026, its largest moves.
• Over 5 years, EV to EBITDA stood at 141.91 in 2022, then sank by 289.99% to 269.62 in 2023, then surged by 88.01% to 32.31 in 2024, then jumped by 44.95% to 17.79 in 2025, then soared by 187.21% to 15.51 in 2026.
• The last three EV to EBITDA figures came in at 15.51 (Q2 2026), 0.56 (Q1 2026), and 17.79 (Q4 2025), per Business Quant data.